scholarly article | Q13442814 |
P2093 | author name string | Wei Wu | |
Deng-Fu Yao | |||
Jian-Hua Zhu | |||
Xian-Yong Meng | |||
Xin-Hua Wu | |||
Deng-Bing Yao | |||
Li-Wei Qiu | |||
Dao-Rong Jiang | |||
Zhi-Zhen Dong | |||
P2860 | cites work | Members of the human glyceraldehyde-3-phosphate dehydrogenase-related gene family map to dispersed chromosomal locations | Q28279849 |
Angiogenesis in health and disease | Q29614541 | ||
Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma | Q31148803 | ||
The IGF axis and hepatocarcinogenesis | Q33918694 | ||
A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. | Q34124264 | ||
Cancer epidemiology in the last century and the next decade | Q34253597 | ||
Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma | Q34655130 | ||
The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin | Q34792237 | ||
Hepatitis B virus genotypes and hepatocellular carcinoma in Japan | Q35612676 | ||
The role of the IGF axis in hepatocarcinogenesis | Q35622480 | ||
PTEN modulates insulin-like growth factor II (IGF-II)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF-II expression in hepatoma cells | Q40639993 | ||
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study | Q40650650 | ||
Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma | Q40860429 | ||
The role of insulin-like growth factor II in the malignant transformation of rat liver oval cells | Q41119539 | ||
Mutations in a hydrophilic part of the core gene of hepatitis C virus in patients with hepatocellular carcinoma in China | Q42981714 | ||
Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites | Q43031257 | ||
Incidence of hepatitis C virus (HCV) antibodies and HCV-RNA in blood donors and patients with liver diseases in the inshore area of the Yangtze River | Q43036016 | ||
Virological features of hepatitis C virus infection in patients with liver diseases in the inshore area of the Yangtze River | Q43036251 | ||
Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma. An in situ hybridization and immunohistochemical study | Q45141524 | ||
The expression of insulin-like growth factor II, hepatitis B virus X antigen and p21 in experimental hepatocarcinogenesis in tree shrews. | Q45748850 | ||
Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression | Q45783000 | ||
Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver | Q47872943 | ||
Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity | Q47886447 | ||
In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma. | Q48019186 | ||
Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines. | Q53427783 | ||
Human insulin-like growth factor I and II messenger RNA: isolation of complementary DNA and analysis of expression | Q69452823 | ||
Differential expression of transforming growth factor a and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma | Q71870169 | ||
Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma | Q72511270 | ||
Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats | Q73002025 | ||
Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver | Q73107790 | ||
Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma | Q73321524 | ||
Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma | Q73459294 | ||
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma | Q74093462 | ||
Molecular pathogenesis of human hepatocellular carcinoma | Q74543031 | ||
Expression of insulin-like growth factor II mRNA in hepatocellular carcinoma | Q77379667 | ||
P433 | issue | 30 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 4655-4660 | |
P577 | publication date | 2005-08-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma | |
P478 | volume | 11 |
Q46553511 | Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis |
Q85224661 | Characteristics of Hepatic IGF-II Expression and Monitored Levels of Circulating IGF-II mRNA in Metastasis of Hepatocellular Carcinoma |
Q37534945 | Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring |
Q36011412 | Circulating tumor cells measurements in hepatocellular carcinoma |
Q40316507 | Differential Expression of Glypican-3 and Insulin–Like Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian Patients |
Q37327775 | Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells |
Q33866121 | Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma |
Q39034561 | Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma |
Q37503151 | Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats |
Q52558393 | Insulin-Like Growth Factor (IGF) System in Liver Diseases. |
Q37047067 | Insulin-like growth factor: current concepts and new developments in cancer therapy |
Q47113848 | MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma |
Q42936819 | Molecular mechanisms of progression in human hepatocarcinogenesis |
Q37113552 | Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. |
Q90326478 | Relationship between Metal Pollution and Gene Expression of Insulin-like Growth Factor II |
Q37809251 | Signaling Networks in Human Hepatocarcinogenesis—Novel Aspects and Therapeutic Options |
Q40214305 | Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma |
Q27006846 | Targeting the insulin-like growth factor pathway in hepatocellular carcinoma |
Q34182483 | The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets |
Q36960897 | Trace element concentration in primary liver cancers--a systematic review |
Search more.